Post-earnings recap
Reported
Wed, Jan 24, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Abbott Labs reported an EPS of $0.74, slightly missing expectations, but the stock rose 4.20% in reaction. This increase may reflect investor confidence in the company's long-term growth strategy and management's positive outlook despite the EPS miss. The lack of revenue data and guidance may leave some investors cautious moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.74 | N/A | -0.07% |
Management expressed satisfaction with the quarter's performance despite missing EPS expectations. They emphasized a commitment to innovation and growth.
We are pleased with our overall performance this quarter.
Our focus remains on innovation and expanding our product offerings.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—